デジタル/電気血圧計：市場洞察・競合環境・市場予測 (～2030年)

デジタル/電気血圧計の市場規模は、2023年の9億7,778万米ドルから、2024年から2030年の予測期間中にCAGR 10.57％で推移し、2030年には17億8,388万米ドルに達すると予測されています。

高血圧やその他の循環器障害の発生率の増加が、定期的な血圧モニタリングの需要に拍車をかけ、デジタル/電気血圧計市場を牽引しています。これらの疾患では、リスクを管理するために継続的なモニタリングが必要となることが多く、家庭用機器への依存度が高まっています。健康意識の高まりが定期的なモニタリングを後押しし、デジタル血圧計はその使いやすさと携帯性で人気を集めています。さらに、Bluetooth接続やスマートフォンとの連携など、継続的な技術革新が消費者とヘルスケアプロバイダーの双方への訴求力を高めており、市場の成長をさらに後押ししています。このような治療の選択肢の拡大と競合の激化が患者の転帰を向上させ、2024年から2030年までの市場成長を促進する見通しです。

デジタル/電気血圧計市場の力学：

世界保健機関 (WHO) の2023年の最新データによると、世界の30～79歳の成人の推定12億8,000万人が高血圧であり、その大部分 (3分の2) は低・中所得国に居住しています。高血圧の成人の推定46％は自分の症状に気づいておらず、診断を受けて治療を受けているのは半数以下 (42％) です。

British Heart Foundationの2024年の最新データによると、世界全体で約6億2,000万人 (約13人に1人) が心臓・循環器疾患を抱えています。さらに、同データによると、2021年の心臓・循環器疾患の有病率は欧州で1億人、アジアとオーストラリアで3億4,000万人でした。さらに、虚血性冠動脈心疾患は、世界でもっとも多く診断され、推定2億人が罹患しています。約1億1,000万人の男性と8,000万人の女性が罹患しています。

高血圧は、心臓発作、脳卒中、心不全を含むさまざまな心血管疾患の主要な危険因子であるため、これらの疾患を効果的に管理するために、血圧を定期的かつ正確にモニターする必要性が高まっています。したがって、デジタル血圧計は、ユーザーフレンドリーなインターフェイス、携帯性、広範な医療訓練を必要とせずに信頼性の高い測定値を提供する能力を備えた、患者と医療提供者の両方にとって不可欠なツールとなっており、世界のデジタル/電気血圧計市場を拡大させています。

上記の要因に加え、診断精度を高める新技術の開発など、デジタル/電気血圧計の分野における技術的進歩もデジタル/電気血圧計市場の成長を助けると期待されています。

当レポートでは、世界のデジタル/電気血圧計の市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 デジタル/電気血圧計市場：イントロダクション

第2章 デジタル/電気血圧計市場：エグゼクティブサマリー

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 デジタル/電気血圧計市場：主要要因分析

• 市場促進要因
  • 高血圧、心血管疾患、その他の循環器系疾患の発生率の増加
  • 健康に対する意識の向上
  • デジタル/電気血圧計の分野における技術進歩の進展
• 市場抑制要因・課題
  • デジタル/電気血圧計に関する精度の懸念
  • 血圧計の継続的な再校正の必要性
• 市場機会
  • ウェアラブルデバイスの出現・遠隔患者モニタリングへの移行の増加

第6章 デジタル/電気血圧計市場：ポーターのファイブフォース分析

第7章 デジタル/電気血圧計市場：市場評価

• 製品タイプ別
  • 上腕
  • 手首
• 技術別
  • 完全自動
  • 半自動
• ポータビリティ
  • ポータブル
  • 非ポータブル
• エンドユーザー別
  • 病院・クリニック
  • 外来診療センター
  • 在宅ケア
  • その他
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 デジタル/電気血圧計市場：企業・製品プロファイル

• OMRON Healthcare, Inc.
• Hill-Rom Services, Inc.
• A&D Company Limited
• SunTech Medical, Inc.
• American Diagnostic Corporation
• Withings
• General Electric Company
• Microlife Corporation
• GF Health Products, Inc.
• Spacelabs Healthcare
• Rudolf Riester GmbH
• Contec Medical Systems Co., Ltd.
• ARCHOS(TM)
• Panasonic Corporation
• Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd.
• ERKA Kallmeyer Medizintechnik GmbH & Co. KG.
• BOSCH + SOHN GmbH u. Co. KG.
• Beijing Choice Electronic Tech Co., Ltd.
• Koninklijke Philips N.V.
• SPENGLER HOLTEX Group

第9章 KOLの見解

第10章 プロジェクトアプローチ

第11章 DelveInsightについて

第12章 免責事項・お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Digital/Electrical Sphygmomanometer Market in Global (2021-2030)
• Table 3: Digital/Electrical Sphygmomanometer Market in Global by Product Type (2021-2030)
• Table 4: Digital/Electrical Sphygmomanometer Market in Global by Technology (2021-2030)
• Table 5: Digital/Electrical Sphygmomanometer Market in Global by Portability (2021-2030)
• Table 6: Digital/Electrical Sphygmomanometer Market in Global by End-User (2021-2030)
• Table 7: Digital/Electrical Sphygmomanometer Market in Global by Geography (2021-2030)
• Table 8: Digital/Electrical Sphygmomanometer Market in North America (2021-2030)
• Table 9: Digital/Electrical Sphygmomanometer Market in the United States (2021-2030)
• Table 10: Digital/Electrical Sphygmomanometer Market in Canada (2021-2030)
• Table 11: Digital/Electrical Sphygmomanometer Market in Mexico (2021-2030)
• Table 12: Digital/Electrical Sphygmomanometer Market in Europe (2021-2030)
• Table 13: Digital/Electrical Sphygmomanometer Market in France (2021-2030)
• Table 14: Digital/Electrical Sphygmomanometer Market in Germany (2021-2030)
• Table 15: Digital/Electrical Sphygmomanometer Market in United Kingdom (2021-2030)
• Table 16: Digital/Electrical Sphygmomanometer Market in Italy (2021-2030)
• Table 17: Digital/Electrical Sphygmomanometer Market in Spain (2021-2030)
• Table 18: Digital/Electrical Sphygmomanometer Market in the Rest of Europe (2021-2030)
• Table 19: Digital/Electrical Sphygmomanometer Market in Asia-Pacific (2021-2030)
• Table 20: Digital/Electrical Sphygmomanometer Market in China (2021-2030)
• Table 21: Digital/Electrical Sphygmomanometer Market in Japan (2021-2030)
• Table 22: Digital/Electrical Sphygmomanometer Market in India (2021-2030)
• Table 23: Digital/Electrical Sphygmomanometer Market in Australia (2021-2030)
• Table 24: Digital/Electrical Sphygmomanometer Market in South Korea (2021-2030)
• Table 25: Digital/Electrical Sphygmomanometer Market in Rest of Asia-Pacific (2021-2030)
• Table 26: Digital/Electrical Sphygmomanometer Market in the Rest of the World (2021-2030)
• Table 27: Digital/Electrical Sphygmomanometer Market in the Middle East (2021-2030)
• Table 28: Digital/Electrical Sphygmomanometer Market in Africa (2021-2030)
• Table 29: Digital/Electrical Sphygmomanometer Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Digital/Electrical Sphygmomanometer Market in Global (2021-2030)
• Figure 3: Digital/Electrical Sphygmomanometer Market in Global by Product Type (2021-2030)
• Figure 4: Digital/Electrical Sphygmomanometer Market in Global by Technology (2021-2030)
• Figure 5: Digital/Electrical Sphygmomanometer Market in Global by Portability (2021-2030)
• Figure 6: Digital/Electrical Sphygmomanometer Market in Global by End-User (2021-2030)
• Figure 7: Digital/Electrical Sphygmomanometer Market in Global by Geography (2021-2030)
• Figure 8: Digital/Electrical Sphygmomanometer Market in North America (2021-2030)
• Figure 9: Digital/Electrical Sphygmomanometer Market in the United States (2021-2030)
• Figure 10: Digital/Electrical Sphygmomanometer Market in Canada (2021-2030)
• Figure 11: Digital/Electrical Sphygmomanometer Market in Mexico (2021-2030)
• Figure 12: Digital/Electrical Sphygmomanometer Market in Europe (2021-2030)
• Figure 13: Digital/Electrical Sphygmomanometer Market in France (2021-2030)
• Figure 14: Digital/Electrical Sphygmomanometer Market in Germany (2021-2030)
• Figure 15: Digital/Electrical Sphygmomanometer Market in United Kingdom (2021-2030)
• Figure 16: Digital/Electrical Sphygmomanometer Market in Italy (2021-2030)
• Figure 17: Digital/Electrical Sphygmomanometer Market in Spain (2021-2030)
• Figure 18: Digital/Electrical Sphygmomanometer Market in the Rest of Europe (2021-2030)
• Figure 19: Digital/Electrical Sphygmomanometer Market in Asia-Pacific (2021-2030)
• Figure 20: Digital/Electrical Sphygmomanometer Market in China (2021-2030)
• Figure 21: Digital/Electrical Sphygmomanometer Market in Japan (2021-2030)
• Figure 22: Digital/Electrical Sphygmomanometer Market in India (2021-2030)
• Figure 23: Digital/Electrical Sphygmomanometer Market in Australia (2021-2030)
• Figure 24: Digital/Electrical Sphygmomanometer Market in South Korea (2021-2030)
• Figure 25: Digital/Electrical Sphygmomanometer Market in Rest of Asia-Pacific (2021-2030)
• Figure 26: Digital/Electrical Sphygmomanometer Market in the Rest of the World (2021-2030)
• Figure 27: Digital/Electrical Sphygmomanometer Market in the Middle East (2021-2030)
• Figure 28: Digital/Electrical Sphygmomanometer Market in Africa (2021-2030)
• Figure 29: Digital/Electrical Sphygmomanometer Market in South America (2021-2030)
• Figure 30: Market Drivers
• Figure 31: Market Barriers
• Figure 32: Market Opportunities
• Figure 33: PORTER'S Five Force Analysis

Digital/Electrical Sphygmomanometer Market by Product Type (Upper Arm and Wrist Type), Technology (Full-Automatic and Semi-Automatic), Portability (Portable and Non-Portable), End-User (Hospitals & Clinics, Ambulatory Care Centers, Home Care Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increase in incidence of hypertension, other circulatory system disorders, and growing technological advancements in the field of digital/electrical sphygmomanometer.

The global digital/electrical sphygmomanometer market was valued at USD 977.78 million in 2023, growing at a CAGR of 10.57% during the forecast period from 2024 to 2030 to reach USD 1,783.88 million by 2030. The increasing incidence of hypertension and other circulatory disorders has fueled the demand for regular blood pressure monitoring, driving the market for digital/electrical sphygmomanometers. These disorders often require continuous monitoring to manage risks, which increases reliance on home-use devices. Increased health awareness is boosting regular monitoring, making digital sphygmomanometers popular for their ease of use and portability. Additionally, continuous innovations, such as bluetooth connectivity and smartphone integration, are enhancing their appeal to both consumers and healthcare providers, further propelling market growth. This expansion of treatment options and increased competition enhances patient outcomes and propels market growth from 2024 to 2030.

Digital/Electrical Sphygmomanometer Market Dynamics:

As per the latest data provided by World Health Organization (2023), an estimated 1.28 billion adults aged 30-79 years worldwide had hypertension, with most (two-thirds) residing in low- and middle-income countries. An estimated 46% of adults with hypertension were unaware of their condition, and less than half (42%) had been diagnosed and treated.

According to a recent data provided by British Heart Foundation (2024), globally, approximately 620 million people, or about 1 in 13 individuals, lived with heart and circulatory diseases. Additionally, as per the same source, the prevalence of heart and circulatory diseases was 100 million in Europe and 340 million in Asia and Australia in 2021. Furthermore, as per the recent data provided by the British Heart Foundation (2024), coronary (ischemic) heart disease, was the most commonly diagnosed worldwide, affected an estimated 200 million people globally. Approximately 110 million men and 80 million women were affected. Additionally, around 56 million women and 45 million men were stroke survivors. It was estimated that at least 13 million people worldwide lived with congenital heart disease, with potentially millions more undiagnosed.

As hypertension is a major risk factor for various cardiovascular conditions, including heart attacks, strokes, and heart failure, there is an increasing need for regular and accurate monitoring of blood pressure to manage these diseases effectively. Thus, digital sphygmomanometers, with their user-friendly interfaces, portability, and ability to provide reliable readings without requiring extensive medical training, have become indispensable tools for both patients and healthcare providers thereby escalating the overall market of digital/electrical sphygmomanometer across the globe.

Along with the factors mentioned above, technological advancements in the field of digital/electrical sphygmomanometer such as the development of new techniques to enhance the yield and diagnostic accuracy are also expected to aid in the growth of the digital/electrical sphygmomanometer market. For instance, in January 2022, Aktiia announced a landmark hypertension trial in the United States in collaboration with a top US hypertension center, for its world's 24/7 blood pressure monitor, which automatically gathers over 100x the data and has over 10x the engagement of other blood pressure monitors.

However, digital/electrical sphygmomanometer being very sensitive due to which body movements affect its accuracy and the need for continuous recalibration of the devices may be certain limiting factors of the digital/electrical sphygmomanometer market growth.

Digital/Electrical Sphygmomanometer Market Segment Analysis:

Digital/Electrical Sphygmomanometer Market by Product Type (Upper Arm and Wrist Type), Technology (Full-Automatic and Semi-Automatic), Portability (Portable and Non-Portable), End-User (Hospitals & Clinics, Ambulatory Care Centers, Home Care Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the overall digital/electrical sphygmomanometer market, the wrist type digital/electrical sphygmomanometer are expected to hold the largest share in the year 2023. Wrist-worn digital/electrical sphygmomanometers are playing a significant role in boosting the overall market for blood pressure monitoring devices. Their unique design and user-friendly features cater to a growing demand for convenience, portability, and real-time health monitoring, contributing to their increasing popularity among consumers and healthcare providers alike.

Additionally, the primary advantages of wrist-worn sphygmomanometers is their portability. Wrist-worn models are compact and lightweight, making them ideal for users who need to monitor their blood pressure regularly while on the go. This convenience appeals to a broad range of consumers, including those who travel frequently or have busy lifestyles, thereby expanding the market reach of digital sphygmomanometers. These devices are typically easier to position and operate than their upper-arm counterparts, which can be especially beneficial for elderly users or individuals with limited mobility. The simplicity of wrist-worn sphygmomanometers encourages more frequent monitoring, aligning with the growing trend of proactive health management. As people become more aware of the importance of tracking their blood pressure regularly to prevent or manage conditions like hypertension, the demand for user-friendly, accessible devices increases, further boosting the market.

Furthermore, the technological advancements in wrist-worn digital sphygmomanometers are also contributing to their rising popularity. Modern devices often feature integration with smartphones and other digital health platforms, allowing users to easily track and analyze their blood pressure data over time. This ability to monitor trends and share data with healthcare providers enhances the utility of wrist-worn devices, making them an attractive option for tech-savvy consumers and those managing chronic conditions. For instance, in June 2022, LiveMetric announced the launch of LiveOne, the world's first 510(k) FDA-cleared nano-sensor technology for continuous blood pressure monitoring. This wrist-worn, cuff-free device provided real-time measurements every 10 seconds, improving care for hypertension and cardiovascular patients. Hence, all the above-mentioned factors are expected to generate considerable revenue of the segment pushing the overall growth of the global digital/electrical sphygmomanometer market during the forecast period.

North America is expected to dominate the overall digital/electrical sphygmomanometer market:

Among all the regions, North America is expected to hold the largest share in the global digital/electrical sphygmomanometer market in 2023. Owing to significant growth factors such as hypertension, cardiovascular diseases. Additionally, increasing health awareness, rising government initiatives, and increasing product launches and product approvals are expected to aid in the growth of the North American digital/electrical sphygmomanometer market during the forecast period from 2024 to 2030.

According to the latest data provided by the Centre for Disease Control and Prevention (2023), approximately, 48.1% population of adults age 18 and older in the United States are living with hypertension. Additionally, as per the recent data from the Centers for Disease Control and Prevention (2024), approximately 4.9% of adults were diagnosed with coronary heart disease in 2022. Furthermore, by 2023, an estimated 12.1 million individuals in the United States were projected to have atrial fibrillation. Additionally, each year, over 795,000 people in the U.S. experience a stroke, with around 610,000 of these being first-time strokes. Notably, nearly 185,000 of these strokes, or about one in four, occur in individuals who have previously had a stroke. With hypertension being a critical risk factor for cardiovascular conditions, including heart attacks, strokes, and heart failure, there is an escalating need for reliable and consistent blood pressure monitoring. Digital sphygmomanometers, with their user-friendly design, portability, and precision, have become indispensable for effective disease management. This trend is accelerating the growth of the digital/electrical sphygmomanometers across the region.

Furthermore, the increased emphasis on product development activities and high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for digital/electrical sphygmomanometer. For instance, in March 2021, Qardio, Inc. announced the US Food and Drug Administration (FDA) 510k clearance for its QardioCore ambulatory ECG device.

Therefore, the above-mentioned factors are expected to bolster the growth of the digital/electrical sphygmomanometer market in the North America during the forecast period.

Digital/Electrical Sphygmomanometer Market Key Players:

Some of the key market players operating in the Digital/Electrical Sphygmomanometer market include OMRON Healthcare, Inc., Hill-Rom Services, Inc., A&D Company Limited, SunTech Medical, Inc., American Diagnostic Corporation, Withings, General Electric Company, Microlife Corporation, GF Health Products, Inc., Spacelabs Healthcare, Rudolf Riester GmbH, Contec Medical Systems Co., Ltd., ARCHOS(TM), Panasonic Corporation, Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd., ERKA Kallmeyer Medizintechnik GmbH & Co. KG., BOSCH + SOHN GmbH u. Co. KG., Beijing Choice Electronic Tech Co., Ltd, Koninklijke Philips N.V., SPENGLER HOLTEX Group, and others.

Recent Developmental Activities in the Digital/Electrical Sphygmomanometer Market:

• In January 2024, Nanowear announced the FDA 510(k) clearance for SimpleSense-BP, AI-enabled continuous blood pressure monitoring and for hypertension diagnostic management.
• In August 2023, Corsano Health launched CardioWatch EU-MDR , a cuffless blood pressure monitor.
• In September 2022, Gramin received FDA clearance for smart BPM Smart Blood Pressure Monitor.
• In August 2022, Sensifree Ltd. Received CE certificate for SentiCor-100(R) in compliance with the new EU MDR.
• In February 2022, Abbott announced the US Food and Drug Administration (FDA) approval of an expanded indication for its CardioMEMS(TM) HF System to support the care of more people living with heart failure. The sensor provides an early warning system enabling doctors to protect against worsening heart failure.

Key Takeaways From the Digital/Electrical Sphygmomanometer Market Report Study:

• Market size analysis for current digital/electrical sphygmomanometer size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the digital/electrical sphygmomanometer market.
• Various opportunities available for the other competitors in the digital/electrical sphygmomanometer market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current digital/electrical sphygmomanometer market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for digital/electrical sphygmomanometer market growth in the coming future?

Target Audience who can be Benefited From This Digital/Electrical Sphygmomanometer Market Report Study:

• Digital/electrical sphygmomanometer product providers
• Research organizations and consulting companies
• Digital/electrical sphygmomanometer -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in digital/electrical sphygmomanometer
• Various end-users who want to know more about the digital/electrical sphygmomanometer market and the latest technological developments in the digital/electrical sphygmomanometer market.

Frequently Asked Questions for the Digital/Electrical Sphygmomanometer Market:

1. What are digital/electrical sphygmomanometer?

• Sphygmomanometers are medical devices that are used to measure blood pressure (mainly in arteries). These devices are of three types mainly mercury sphygmomanometers, an aneroid sphygmomanometer, and electronic/digital sphygmomanometer.

2. What is the market for digital/electrical sphygmomanometer?

• The global digital/electrical sphygmomanometer market was valued at USD 977.78 million in 2023, growing at a CAGR of 10.57% during the forecast period from 2024 to 2030 to reach USD 1,783.88 million by 2030.

3. What are the drivers for the digital/electrical sphygmomanometer market?

• The rising incidence of hypertension and other circulatory system disorders has driven demand for accurate, user-friendly blood pressure monitors. Increased health awareness is boosting regular monitoring, making digital sphygmomanometers popular for their ease of use and portability. Additionally, continuous innovations, such as bluetooth connectivity and smartphone integration, are enhancing their appeal to both consumers and healthcare providers, further propelling market growth. This expansion of treatment options and increased competition enhances patient outcomes and propels market growth from 2024 to 2030.

4. Who are the key players operating in the digital/electrical sphygmomanometer market?

• Some of the key market players operating in the digital/electrical sphygmomanometer market include OMRON Healthcare, Inc., Hill-Rom Services, Inc., A&D Company Limited, SunTech Medical, Inc., American Diagnostic Corporation, Withings, General Electric Company, Microlife Corporation, GF Health Products, Inc., Spacelabs Healthcare, Rudolf Riester GmbH, Contec Medical Systems Co., Ltd., ARCHOS(TM), Panasonic Corporation, Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd., ERKA Kallmeyer Medizintechnik GmbH & Co. KG., BOSCH + SOHN GmbH u. Co. KG., Beijing Choice Electronic Tech Co., Ltd., Koninklijke Philips N.V., SPENGLER HOLTEX Group and others.

5. Which region has the highest share in the digital/electrical sphygmomanometer market?

• Among all the regions, North America is expected to hold the largest share in the global digital/electrical sphygmomanometer market in 2023. Owing to significant growth factors such as hypertension, cardiovascular diseases, increasing health awareness, rising government initiatives, and increased government product regulations are expected to aid in the growth of the North American digital/electrical sphygmomanometer market during the forecast period from 2024 to 2030.

Table of Contents

1. Digital/Electrical Sphygmomanometer Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Digital/Electrical Sphygmomanometer Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Digital/Electrical Sphygmomanometer Market Key Factors Analysis

• 5.1. Digital/Electrical Sphygmomanometer Market Drivers
  • 5.1.1. Increasing incidence of hypertension, cardiovascular diseases, and other circulatory system disorders
  • 5.1.2. Increasing awareness for health
  • 5.1.3. Growing technological advancements in the field of digital/electrical sphygmomanometer
• 5.2. Digital/Electrical Sphygmomanometer Market Restraints and Challenges
  • 5.2.1. Accuracy concerns related to digital/electrical sphygmomanometer
  • 5.2.2. Need for continuous recalibration of sphygmomanometer devices
• 5.3. Digital/Electrical Sphygmomanometer Market Opportunities
  • 5.3.1. Increase in shift toward remote patient monitoring, combined with the emergence of wearable devices

6. Digital/Electrical Sphygmomanometer Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Digital/Electrical Sphygmomanometer Market Assessment

• 7.1. By Product Type
  • 7.1.1. Upper Arm
  • 7.1.2. Wrist Type
• 7.2. By Technology
  • 7.2.1. Full-Automatic
  • 7.2.2. Semi-Automatic
• 7.3. By Portability
  • 7.3.1. Portable
  • 7.3.2. Non-Portable
• 7.4. By End-User
  • 7.4.1. Hospitals & Clinics
  • 7.4.2. Ambulatory Care Centers
  • 7.4.3. Homecare Settings
  • 7.4.4. Others
• 7.5. By Geography
  • 7.5.1. North America
    • 7.5.1.1. United States Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.1.2. Canada Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.1.3. Mexico Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
  • 7.5.2. Europe
    • 7.5.2.1. France Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.2.2. Germany Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.2.3. United Kingdom Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.2.4. Italy Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.2.5. Spain Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.2.6. Rest of Europe Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
  • 7.5.3. Asia-Pacific
    • 7.5.3.1. China Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.3.2. Japan Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.3.3. India Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.3.4. Australia Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.3.5. South Korea Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.3.6. Rest of Asia-Pacific Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
  • 7.5.4. Rest of the World (RoW)
    • 7.5.4.1. Middle East Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.4.2. Africa Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)
    • 7.5.4.3. South America Digital/Electrical Sphygmomanometer Market Size in USD Million (2021-2030)

8. Digital/Electrical Sphygmomanometer Market Company and Product Profiles

• 8.1. OMRON Healthcare, Inc.
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Hill-Rom Services, Inc.
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. A&D Company Limited
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. SunTech Medical, Inc.
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. American Diagnostic Corporation
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Withings
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. General Electric Company
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Microlife Corporation
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. GF Health Products, Inc.
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Spacelabs Healthcare
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Rudolf Riester GmbH
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Contec Medical Systems Co., Ltd.
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. ARCHOS(TM)
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Panasonic Corporation
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd.
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. ERKA Kallmeyer Medizintechnik GmbH & Co. KG.
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. BOSCH + SOHN GmbH u. Co. KG.
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Beijing Choice Electronic Tech Co., Ltd.
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Koninklijke Philips N.V.
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. SPENGLER HOLTEX Group
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us